Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma

[1]  H. Lee,et al.  Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer , 2022, Scientific reports.

[2]  R. Amini,et al.  miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI , 2021, BioImpacts : BI.

[3]  R. Dhanasekaran,et al.  Current and Emerging Tools for Hepatocellular Carcinoma Surveillance , 2021, Hepatology communications.

[4]  Hong Tang,et al.  Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma , 2021, Frontiers in Cell and Developmental Biology.

[5]  N. Ehsan,et al.  Evaluation of HCV-related liver fibrosis post-successful DAA therapy , 2021, Egyptian Liver Journal.

[6]  Guangrong Huang,et al.  miR-1825 Accelerates Cell Proliferation and Inhibits Cell Apoptosis of Prostate Cancer via Targeting Suppressor of Cancer Cell Invasion , 2021, Journal of Biomaterials and Tissue Engineering.

[7]  Yongliang Zhu,et al.  Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors , 2020, BMC cancer.

[8]  Zheng Guo,et al.  Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples , 2020, Briefings Bioinform..

[9]  Jia Wei,et al.  Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma , 2020, OncoTargets and therapy.

[10]  Yuping Sun,et al.  Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway , 2020, World Journal of Surgical Oncology.

[11]  A. Alizadeh,et al.  Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells. , 2020, European journal of pharmacology.

[12]  Weiyi Wang,et al.  Advances in the early diagnosis of hepatocellular carcinoma , 2020, Genes & diseases.

[13]  Jia Wei,et al.  Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer , 2020, Journal of Cancer.

[14]  T. Aboushousha,et al.  Effect of Interferon-Beta (IFN-β) on tumor suppressor and apoptotic markers in hepatocellular carcinoma cell line , 2019, International Journal of Research in Pharmaceutical Sciences.

[15]  Gregory J. Gores,et al.  A global view of hepatocellular carcinoma: trends, risk, prevention and management , 2019, Nature Reviews Gastroenterology & Hepatology.

[16]  S. Uddin,et al.  Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies , 2019, Cells.

[17]  S. Zada,et al.  MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients , 2019, Archives of medical science : AMS.

[18]  J. Dai,et al.  Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma. , 2019, Cancer biomarkers : section A of Disease markers.

[19]  T. Han,et al.  Five microRNAs in serum as potential biomarkers for prostate cancer risk assessment and therapeutic intervention , 2018, International Urology and Nephrology.

[20]  L. Xue,et al.  Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage , 2018, Clinical Epigenetics.

[21]  M. Heikenwalder,et al.  The immunology of hepatocellular carcinoma , 2018, Nature Immunology.

[22]  Fengqiang Wang,et al.  miR-1290 Contributes to Colorectal Cancer Cell Proliferation by Targeting INPP4B. , 2017, Oncology research.

[23]  Jianguo Wu,et al.  Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells. , 2017, Cancer letters.

[24]  Chun Zeng,et al.  A novel serum microRNA-based identification and classification biomarker of human glioma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[25]  Wei-Wei Zhang,et al.  Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma , 2017, Cell Death & Disease.

[26]  C. Creighton,et al.  Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens , 2016, BMC Cancer.

[27]  C. Blanpain,et al.  Cancer Stem Cells: Basic Concepts and Therapeutic Implications. , 2016, Annual review of pathology.

[28]  Qiang Chen,et al.  sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells. , 2016, Gene.

[29]  Qing Luo,et al.  Liver cancer stem cell markers: Progression and therapeutic implications. , 2016, World journal of gastroenterology.

[30]  H. An,et al.  Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. , 2016, Lung cancer.

[31]  Baosheng Li,et al.  MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  S. Pan,et al.  miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. , 2015, Journal of thoracic disease.

[33]  P. Zuo,et al.  Antagomir-1290 suppresses CD133+ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase , 2015, Tumor Biology.

[34]  Q. Cheng,et al.  Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening , 2015, Medicine.

[35]  H. Fox,et al.  The evolutionary young miR-1290 favors mitotic exit and differentiation of human neural progenitors through altering the cell cycle proteins , 2014, Cell Death and Disease.

[36]  X. Wang,et al.  Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma , 2013, Hepatology.

[37]  C. Spits,et al.  Genetic and epigenetic instability in human pluripotent stem cells. , 2013, Human reproduction update.

[38]  Yongliang Zhu,et al.  Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. , 2013, Cancer letters.

[39]  R. Shao,et al.  CD133+EpCAM+ Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells , 2012, International journal of biological sciences.

[40]  R. May,et al.  Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts , 2011, Journal of Virology.

[41]  A. Schnerch,et al.  Characterization of human embryonic stem cells with features of neoplastic progression , 2009, Nature Biotechnology.

[42]  Ryan D. Morin,et al.  Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. , 2008, Genome research.

[43]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[44]  Y. Chawla,et al.  Immunology of hepatocellular carcinoma. , 1991, The Italian journal of gastroenterology.

[45]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .